FdaApplication

NDA 017604

Back to search

Identifiers

Properties

PropertyValue
applicant_namePHARMACO LLC
application_typeNDA
approval_date2009-07-21

Products (3)

ProductActive ingredientStrengthDosage form
NALFONFENOPROFEN CALCIUMEQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL
NALFONFENOPROFEN CALCIUMEQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL
NALFONFENOPROFEN CALCIUMEQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL

3 products